This inventor holds 1 USPTO granted patent. Top assignee: Zentaris Ag. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Monica Thelestam: Innovator in Ras Protein Inactivation
Introduction
Monica Thelestam is a notable inventor based in Soina, Sweden. She has made significant contributions to the field of biotechnology, particularly in the area of protein inactivation. Her innovative work focuses on developing methods to treat disorders associated with mutations in Ras proto-oncogenes.
Latest Patents
Monica holds a patent for "Agents useful for inactivation of Ras subfamily proteins." This patent describes a method of treating disorders characterized by activating mutations in Ras proto-oncogenes. The method involves contacting cells of a patient suffering from the disorder with a protein that has the toxic activity of toxin LT. This process favors the inactivation of Ras by glucosylation of Ras' threonine 35 in the affected cells. The protein is preferably an immunotoxin that contains the catalytic domain of toxin LT as its toxic component. She has 1 patent to her name.
Career Highlights
Monica Thelestam is associated with Zentaris AG, where she continues to advance her research and development efforts. Her work has the potential to impact the treatment of various cancers and other diseases linked to Ras mutations.
Collaborations
Monica has collaborated with esteemed colleagues such as Christoph Von Eichel-Streiber and Patrice Boquet. Their combined expertise enhances the research and development of innovative therapeutic solutions.
Conclusion
Monica Thelestam is a pioneering inventor whose work in Ras protein inactivation holds promise for future medical advancements. Her contributions to biotechnology are noteworthy and continue to inspire further research in the field.